, Tracking Stock Market Picks
Enter Symbol:
Vertex Pharmaceuticals Incorporated (VRTX) [hlAlert]

up 150.98 %

Vertex Pharmaceuticals Incorporated (VRTX) upgraded to Buy by ThinkEquity

Posted on: Thursday,  Aug 30, 2012  8:25 AM ET by ThinkEquity

ThinkEquity rated Buy Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on 08/30/2012, when the stock price was $53.29. Since
then, Vertex Pharmaceuticals Incorporated has gained 150.99% as of 12/01/2015's recent price of $133.75.
If you would have followed this ThinkEquity's recommendation on VRTX, you would have gained 150.98% of your investment in 1188 days.

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/30/2012 8:25 AM Buy
as of 12/31/2012
1 Week down  -1.38 %
1 Month up  5.30 %
3 Months down  -25.03 %
1 YTD down  -21.37 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2011 8:25 AM Hold
43.59 42.00
3/4/2009 8:25 AM Buy
27.99 34.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy